American Shared Hospital Services (NYSEAMERICAN:AMS) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?

American Shared Hospital Services (NYSEAMERICAN:AMS) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $2.83. American Shared Hospital Services shares last traded at $2.83, with a volume of 2,504 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on shares of American Shared Hospital Services in a research report on Tuesday, January 14th. They set a “hold” rating for the company.

American Shared Hospital Services Trading Up 0.7 %

The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.34. The firm has a market cap of $18.17 million, a P/E ratio of 4.72 and a beta of 0.66.

Hedge Funds Weigh In On American Shared Hospital Services

A hedge fund recently raised its stake in American Shared Hospital Services stock. Renaissance Technologies LLC increased its position in American Shared Hospital Services (NYSEAMERICAN:AMS) by 5.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,225 shares of the company’s stock after acquiring an additional 3,776 shares during the period. Renaissance Technologies LLC owned approximately 1.11% of American Shared Hospital Services worth $227,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 23.16% of the company’s stock.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.